STZ Stock - Constellation Brands, Inc.
Unlock GoAI Insights for STZ
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $10.21B | $9.96B | $9.45B | $8.82B | $8.61B |
| Gross Profit | $5.20B | $4.91B | $4.81B | $4.60B | $4.47B |
| Gross Margin | 51.0% | 49.3% | 50.9% | 52.1% | 51.9% |
| Operating Income | $3.62B | $3.13B | $2.99B | $2.90B | $2.86B |
| Net Income | $-81,400,000 | $1.73B | $-71,000,000 | $-40,400,000 | $2.00B |
| Net Margin | -0.8% | 17.3% | -0.8% | -0.5% | 23.2% |
| EPS | $-0.45 | $9.42 | $-0.37 | $-0.21 | $10.42 |
Constellation Brands, Inc., together with its subsidiaries, produces, imports, markets, and sells beer, wine, and spirits in the United States, Canada, Mexico, New Zealand, and Italy. It provides beer primarily under the Corona Extra, Corona Premier, Corona Familiar, Corona Light, Corona Refresca, Corona Hard Seltzer, Modelo Especial, Modelo Negra, Modelo Chelada, Pacifico, and Victoria brands. The company offers wine under the 7 Moons, Cook's California Champagne, Cooper & Thief, Crafters Union, Kim Crawford, Meiomi, Mount Veeder, Ruffino, SIMI, The Dreaming Tree, Charles Smith, The Prisoner Wine Company, Robert Mondavi, My Favorite Neighbor, and Schrader; and spirits under the Casa Noble, Copper & Kings, High West, Mi CAMPO, Nelson's Green Brier, and SVEDKA brands. It provides its products to wholesale distributors, retailers, on-premise locations, and state alcohol beverage control agencies. Constellation Brands, Inc. was founded in 1945 and is headquartered in Victor, New York.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 17th 2025 | Jefferies | Downgrade | Hold | $154 |
| November 7th 2025 | JP Morgan | Resumed | Neutral | $153 |
| September 12th 2025 | Barclays | Downgrade | Equal Weight | $150 |
| September 3rd 2025 | BNP Paribas Exane | Downgrade | Underperform | $123 |
| August 26th 2025 | BofA Securities | Downgrade | Underperform | $150 |
| July 7th 2025 | Jefferies | Upgrade | Buy | $205 |
| June 25th 2025 | Needham | Reiterated | Buy | $195← $215 |
| May 7th 2025 | Truist | Upgrade | Buy | $215 |
| March 27th 2025 | Needham | Reiterated | Buy | $215← $240 |
| March 20th 2025 | Citigroup | Downgrade | Neutral | $200← $260 |
| February 27th 2025 | Morgan Stanley | Downgrade | Equal Weight | $202← $220 |
| February 3rd 2025 | Piper Sandler | Downgrade | Neutral | $200← $245 |
| January 14th 2025 | Argus | Downgrade | Hold | - |
| January 13th 2025 | Jefferies | Downgrade | Hold | $201← $310 |
| January 13th 2025 | JP Morgan | Downgrade | Neutral | $203← $262 |
Earnings History & Surprises
STZEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 7, 2026 | — | — | — | — |
Q1 2026 | Jan 7, 2026 | $2.66 | — | — | — |
Q4 2025 | Oct 6, 2025 | $3.38 | $3.63 | +7.4% | ✓ BEAT |
Q3 2025 | Jul 1, 2025 | $3.31 | $3.22 | -2.7% | ✗ MISS |
Q2 2025 | Apr 9, 2025 | $2.27 | $2.63 | +15.9% | ✓ BEAT |
Q1 2025 | Jan 10, 2025 | $3.31 | $3.25 | -1.8% | ✗ MISS |
Q4 2024 | Oct 3, 2024 | $4.08 | $4.32 | +5.9% | ✓ BEAT |
Q3 2024 | Jul 3, 2024 | $3.46 | $3.57 | +3.2% | ✓ BEAT |
Q2 2024 | Apr 11, 2024 | $2.08 | $2.26 | +8.7% | ✓ BEAT |
Q1 2024 | Jan 5, 2024 | $3.00 | $3.19 | +6.3% | ✓ BEAT |
Q4 2023 | Oct 5, 2023 | $3.36 | $3.70 | +10.1% | ✓ BEAT |
Q2 2023 | Jun 30, 2023 | $2.83 | $2.91 | +2.8% | ✓ BEAT |
Q2 2023 | Apr 6, 2023 | $1.86 | $1.98 | +6.5% | ✓ BEAT |
Q1 2023 | Jan 5, 2023 | $2.89 | $2.83 | -2.1% | ✗ MISS |
Q4 2022 | Oct 6, 2022 | $2.88 | $3.17 | +10.1% | ✓ BEAT |
Q2 2022 | Jun 30, 2022 | $2.51 | $2.66 | +6.0% | ✓ BEAT |
Q2 2022 | Apr 7, 2022 | $2.10 | $2.37 | +12.9% | ✓ BEAT |
Q1 2022 | Jan 6, 2022 | $2.76 | $3.12 | +13.0% | ✓ BEAT |
Q4 2021 | Oct 6, 2021 | $2.78 | $2.38 | -14.4% | ✗ MISS |
Q2 2021 | Jun 30, 2021 | $2.35 | $2.33 | -0.9% | ✗ MISS |
Latest News
Jefferies Downgrades Constellation Brands to Hold, Lowers Price Target to $154
📉 NegativeLive On CNBC, Sarat Sethi Announces Bought Verisk Analytics; Sold PayPal; Sold Constellation Brands
➖ NeutralPiper Sandler Maintains Neutral on Constellation Brands, Lowers Price Target to $135
📉 NegativeNBC News Congressional Correspondent Julie Tsirkin Posts On X "POTUS "supports the current language in the bill on hemp," per WH official. Sen Rand Paul has long told leadership + industry folks he won't consent to bills unless the loophole is preserved, created by the 2018 farm bill that allows unregulated THC products to be sold nationwide"
➖ NeutralConstellation Brands Files For Offer & Sale From Time To Time Of Up To 21.3M Class A Shares By Selling Stockholders
📉 Negative'Legalizing Medical Marijuana Leads To 'Significant Reductions' In Opioid Prescriptions, Another Study Shows' - Marijuana Moment
📈 PositiveBarclays Maintains Equal-Weight on Constellation Brands, Lowers Price Target to $147
➖ NeutralJP Morgan Maintains Neutral on Constellation Brands, Lowers Price Target to $153
➖ NeutralNeedham Reiterates Buy on Constellation Brands, Maintains $180 Price Target
📈 PositiveMorgan Stanley Maintains Equal-Weight on Constellation Brands, Lowers Price Target to $160
➖ Neutral'Virginia Lawmakers Discuss Steps To Prepare State To Legalize Recreational Marijuana Sales Next Year'- Marijuana Moment
📈 PositiveConstellation Brands shares are trading higher after the company reported better-than-expected Q2 financial results.
📈 PositiveConstellation Brands shares are trading higher after the company reported better-than-expected Q2 financial results.
📈 PositiveConstellation Brands Lowers FY2026 GAAP EPS Guidance from $10.77-$11.07 to $9.86-$10.16 vs $11.35 Est
📉 NegativeConstellation Brands Affirms FY2026 Adj EPS Guidance of $11.30-$11.60 vs $11.49 Est
➖ NeutralConstellation Brands Q2 Adj. EPS $3.63 Beats $3.38 Estimate, Sales $2.481B Beat $2.459B Estimate
📈 PositiveUBS Maintains Buy on Constellation Brands, Lowers Price Target to $175
➖ NeutralGoldman Sachs Maintains Buy on Constellation Brands, Lowers Price Target to $168
➖ Neutral'US May Ease Tariffs on Scotch Whisky to Help Bourbon Industry' -Bloomberg
📈 PositiveShares of cannabis-linked stocks are trading lower after a sector-wide rally yesterday due to President Trump sharing a video that discussed potential medical benefits of CBD for seniors.
➖ NeutralFrequently Asked Questions about STZ
What is STZ's current stock price?
What is the analyst price target for STZ?
What sector is Constellation Brands, Inc. in?
What is STZ's market cap?
Does STZ pay dividends?
Similar Stocks
Consumer Defensive SectorExplore stocks similar to STZ for comparison